Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Inotiv, Inc. Director's Dealing 2017

Mar 15, 2017

34595_dirs_2017-03-15_90c9da05-2e73-499a-92fa-bbc4b038c582.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2017-03-01

Reporting Person: Downing Philip A (VP, Preclinical Srvcs.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-01 Common Stock M 10000 $1.01 Acquired 17000 Direct
2017-03-01 Common Stock F 6235 $1.62 Disposed 10765 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-03-01 Employee Stock Option (right to buy) $1.01 M 10000 Disposed 2020-08-15 Common Stock (10000) Direct